In vitro establishment of cis-diammine-dichloroplatinum(II) resistant lung cancer cell line and modulation of apoptotic gene expression as a mechanism of resistant phenotype

Lung Cancer

Volumn 33, Issue 2-3, 2001, Pages 221-228

  Yoon, Sung Soo ^a   Ahn, Kwang Sung ^c   Kim, Sun Hee ^b   Shim, Young Mok ^b,c   Kim, Jhingook ^b,c  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

A poptosis; cis diammine dichloroplatinum (II); Drug resistance; Lung cancer

Indexed keywords

CISPLATIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DRUG RESISTANCE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LUNG CANCER; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FAS LIGAND PROTEIN; FORMAZANS; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TETRAZOLIUM SALTS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034900063     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00205-7     Document Type: Article

References (34)

1. Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines
2. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): cross-resistance patterns
3. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines
4. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines
5. CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy
6. Modulation of activity of the promoter of the human MDR1 gene by ras and p53
7. Reversal of radiation-induced cisplatin resistance in murine fibrosarcoma cells by selective modulation of the cyclic GMP-dependent transduction pathway
8. Cellular accumulation of the anticancer agent cisplatin
9. Differential modulation of chemosensitivity to alkylating agents and platinum compounds by DNA repair modulators in human lung cancer cell lines
10. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate
11. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
12. Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines
13. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines
14. Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer
15. Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum(II) and (IV) ammine/amine complexes
16. Establishment and characterization of cisplatin-resistant human epidermoid carcinoma cell line, A431 cell
17. Establishment of high and low metastasis cell lines derived from a human tongue squamous cell carcinoma
18. Drug resistance in lung cancer
19. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by Bcl-2
20. Characterization of resistance mechanisms to cis-diamminedichloro-platinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro
21. Altered cell cycle response of drug-resistant lung carcinoma cells to doxorubicin
22. The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli
23. Association between cisplatin resistance and mutation of p53 gene and reduced Bax expression in ovarian carcinoma cell systems
24. Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance
25. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53
26. Independent pathways of p53 induction by cisplatin and X-rays in a cisplatin-resistant ovarian tumor cell line
27. Cell cycle checkpoint evasion and protracted cell cycle arrest in X-irradiated small-cell lung carcinoma cells
28. Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II)
29. Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells
30. Paclitaxel-induced apoptosis in non-small cell lung cancer cell lines is associated with increased caspase-3 activity
31. Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or Bcl-2
32. p21Waf1/Cip1 acts in synergy with Bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell line